VC Fund Investments
Healthtech firm BeatO raises $5.7-M from W Health Ventures, others
New Delhi-based digital care ecosystem for chronic condition management BeatO has raised USD 5.7 million in funding led by US-based venture capital firm W Health Ventures. The funding also saw participation from e-pharmacy Unicorn PharmEasy (a Threpsi Solutions Pvt Ltd brand), Merisis VP and existing investors Orios VP, Leo Capital, and others. The fresh funds will be utilized across two key areas – growth in subscriber base across multiple channels and geographies, and product enhancement to provide care for other cardiometabolic conditions. BeatO's digital health platform combines real-time monitoring through its IoT-connected devices and app ecosystem to provide AI-driven personalized insights and proactive intervention by doctors and health coaches to patients with chronic conditions.
From the Venture Intelligence PE-VC Deal Database: Between Sep-17 and July-20 BeatO had raised more than INR 25 crore from Orios VP, Parkview Capital, Leo Capital and Blume Ventures
Want to receive such news items in your inbox? Click Here to sign up for a trial.
